Sign in

CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464097528
Phone
617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$19,092
in 3 filings, $19K under 10b5-1 plans

Net −$19,092. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. O'Neill Gilmore Neil −$16K CEO sold 2% of stake
  2. Burkly Linda −$2K EVP, CHIEF SCIENTIFIC OFFICER sold 1% of stake
  3. Parison Amy −$1K SVP, Chief Financial Officer sold 3% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-12-22 MULLEN JAMES C CEO Grant or award +36,477 94,150
2021-11-12 Michaels Lisa Anne EVP/Chief Medical Officer Sale −1,568 $38.33 $60K 18,432
2021-11-09 Eaton Bruce EVP, Chief Business Officer Sale −287 $40.61 $12K 28,026
2021-10-26 Connaughton Bernadette Director Grant or award · Stock Option (right to buy) +24,732 24,732
2021-10-18 MULLEN JAMES C CEO Sale −13,805 $38.03 $525K 57,673
2021-09-30 MULLEN JAMES C CEO Grant or award +36,478 71,478
2021-09-03 Reeve Emma Director Grant or award · Stock Option (right to buy) +13,736 13,736
2021-08-09 Eaton Bruce EVP, CHIEF BUSINESS OFFICER Sale −287 $57.17 $16K 68,099
2021-08-09 ROBERTSON MICHELLE Chief Financial Officer Option exercise +2,500 $30.65 $77K 31,235
2021-08-09 ROBERTSON MICHELLE Chief Financial Officer Sale −2,500 $60.00 $150K 28,735
2021-08-09 ROBERTSON MICHELLE Chief Financial Officer Option exercise · Stock Option (right to buy) −2,500 115,000
2021-06-28 ROBERTSON MICHELLE Chief Financial Officer Option exercise +2,500 $30.65 $77K 31,235
2021-06-28 ROBERTSON MICHELLE Chief Financial Officer Sale −2,500 $50.00 $125K 28,735
2021-06-28 ROBERTSON MICHELLE Chief Financial Officer Option exercise · Stock Option (right to buy) −2,500 117,500
2021-06-14 MULLEN JAMES C CEO Grant or award · Stock Option (right to buy) +170,989 170,989
2021-06-14 Shearman Mark S EVP, Chief Scientific Officer Grant or award +32,701 32,701
2021-06-14 Shearman Mark S EVP, Chief Scientific Officer Grant or award · Stock Option (right to buy) +52,718 52,718
2021-06-03 Vaishnaw Akshay Director Grant or award · Stock Option (right to buy) +11,538 11,538
2021-06-03 Scadden David Director Grant or award · Stock Option (right to buy) +11,538 11,538
2021-06-03 Chatterjee Meeta Director Grant or award · Stock Option (right to buy) +11,538 11,538

Page 9 of 15 · 283 trades